Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?
- Citation:
- Leuk Lymphoma vol 53 (11) 2143-50
- Year:
- 2012
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- Received
- Note:
- Pharmas:
- Grants:
- CA04457, CA31946, CA32291, CA33601, CA77440, CA77597, CA77651, CA77658
- Corr. Author:
- Authors:
- Lale Kostakoglu Heiko Schöder Jeffrey L Johnson Nathan C Hall Lawrence H Schwartz David J Straus Ann S LaCasce Sin-Ho Jung Nancy L Bartlett George P Canellos Bruce D Cheson
- Networks:
- Study
- CALGB-50203
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords:
- Adult, Aged, Disease-Free Survival, Fluorodeoxyglucose F18, Hodgkin Disease, Humans, Middle Aged, Multimodal Imaging, Neoplasm Staging, Positron-Emission Tomography, Prospective Studies, Radiopharmaceuticals, Tomography, X-Ray Computed